VIALE, GIULIA
VIALE, GIULIA
Universita' degli Studi di MILANO
Completion Rate and Positive Results Reporting Among Immunotherapy Trials in Breast Cancer, 2004-2023
2024 M. Mariani, G. Viale, B. Galbardi, L. Licata, C. Bosi, M. Dugo, G. Notini, M.M. Naldini, M. Callari, C. Criscitiello, L. Pusztai, G. Bianchini
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer
2023 L. Licata, G. Viale, M. Giuliano, G. Curigliano, M. Chavez-MacGregor, J. Foldi, O. Oke, J. Collins, L. Del Mastro, F. Puglisi, F. Montemurro, C. Vernieri, L. Gerratana, S. Giordano, A. Rognone, L. Sica, O.D. Gentilini, S. Cascinu, L. Pusztai, A. Giordano, C. Criscitiello, G. Bianchini
Breast implant-associated anaplastic large cell lymphoma: A comprehensive review
2020 A. Marra, G. Viale, S. Pileri, G. Pravettoni, G. Viale, F. De Lorenzi, F. Nolè, P. Veronesi, G. Curigliano
Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer
2020 C. Criscitiello, A. Vingiani, P. Maisonneuve, G. Viale, G. Viale, G. Curigliano
What therapies are on the horizon for HER2 positive breast cancer?
2019 G. Viale, S. Morganti, E. Ferraro, P. Zagami, A. Marra, G. Curigliano
Peptide vaccines in early breast cancer
2019 C. Criscitiello, G. Viale, G. Curigliano
A clinical perspective on escalating or de-escalating adjuvant therapy in HER2+ breast cancer
2019 A. Esposito, G. Viale, C. Criscitiello, G. Curigliano
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life
2019 S. Morganti, P. Tarantino, E. Ferraro, P. D'Amico, G. Viale, D. Trapani, B.A. Duso, G. Curigliano
Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer
2018 B. Duso, D. Trapani, G. Viale, C. Criscitiello, P. D'Amico, C. Belli, L. Mazzarella, M. Locatelli, I. Minchella, G. Curigliano
Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis
2018 C. Criscitiello, M. Golshan, W.T. Barry, G. Viale, S. Wong, M. Santangelo, G. Curigliano
Targeting the microenvironment in solid tumors
2018 C. Belli, D. Trapani, G. Viale, P. D'Amico, B. Achutti Duso, P. Della Vigna, F. Orsi, G. Curigliano
Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy
2017 G. Viale, D. Trapani, G. Curigliano
Extending indication of cyclin-dependent kinase 4/6 inhibitors in the adjuvant and neoadjuvant setting
2017 C. Carmen, G. Viale, G. Curigliano
Impact of autoimmune diseases on outcome of patients with early breast cancer
2016 C. Criscitiello, V. Bagnardi, A. Esposito, L. Gelao, B. Santillo, G. Viale, N. Rotmensz, A. Goldhirsch, G. Curigliano
An unusual case of tracheo-pleural fistula and cardiac metastases in oropharyngeal carcinoma: a case report and review of the literature
2016 D. Ferrari, C. Codecà, G. Viale, B. Bocci, F. Broggio, F. Crepaldi, M. Violati, A. Luciani, D. Bauer, L. Moneghini, G. Bulfamante, P. Foa, G. Viale
Anti-epidermal growth factor receptor skin toxicity : a matter of topical hydration
2016 D. Ferrari, C. Codecà, B. Bocci, F. Crepaldi, M. Violati, G. Viale, C. Careri, S. Caldiera, V. Bordin, A. Luciani, S. Zonato, G. Cassinelli, P. Foa
Crosstalk between bone niche and immune system : osteoimmunology signaling as a potential target for cancer treatment
2015 C. Criscitiello, G. Viale, L. Gelao, A. Esposito, M. De Laurentiis, S. De Placido, M. Santangelo, A. Goldhirsch, G. Curigliano
Dinaciclib for the treatment of breast cancer
2014 C. Criscitiello, G. Viale, A. Esposito, G. Curigliano
Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy
2014 C. Criscitiello, L. Gelao, G. Viale, A. Esposito, G. Curigliano